Truist Boosts Meta & Teva Targets, Cuts Tesla: Jan 2026 Research Shifts Explained
Truist Financial’s January research shifts show a balanced view—boosting Meta, Teva, and TI while trimming Tesla and others—offering investors clear signals for tech, health, and industry growth.
4 minutes to read









